"Monoclonal antibody therapeutics are a key area of novel drug discovery. Binding Site’s expertise in manufacturing reagents and assays for the quantification and characterisation of immunoglobulin has led to the development of a number of products with applications in cell line selection, at-line monitoring during fermentation and pharmacokinetic studies." ¹

References

References